PCMC
CSCI

Planning Capital Management Corporation’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Planning Capital Management Corporation’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$8 Hold
2
– – ﹤0.01% 773
2024
Q2 		$9 Buy
+2
New +$15 ﹤0.01% 717

Other funds holding CSCI

National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TC
Truvestments Capital Sarasota, Florida $554M AUM 32.49% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Planning Capital Management Corporation's CSCI Position: Q3 2024 in Review

Planning Capital Management Corporation held its COSCIENS Biopharma Inc. Common Stock (CSCI) position steady in Q3 2024 at 2 shares worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #773.

Planning Capital Management Corporation first reported a position in CSCI in Q2 2024 and has held it in 2 quarters since. The position peaked at $9 in Q2 2024. 9 funds tracked by Wall St. Rank hold CSCI as of Q3 2024.

  • Planning Capital Management Corporation held 2 shares of COSCIENS Biopharma Inc. Common Stock worth $8 as of Q3 2024.
  • Planning Capital Management Corporation left its COSCIENS Biopharma Inc. Common Stock share count unchanged in Q3 2024.
  • COSCIENS Biopharma Inc. Common Stock made up ﹤0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #773 holding.
  • Planning Capital Management Corporation first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2024 and has held it in 2 quarters since.
  • Planning Capital Management Corporation's COSCIENS Biopharma Inc. Common Stock position peaked at $9 in Q2 2024.
  • 9 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.